Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study

BACKGROUND: People with substance use disorder have a high risk of SARS-CoV-2 infection and subsequent poor outcomes. Few studies have evaluated COVID-19 vaccine effectiveness among people with substance use disorder. We aimed to estimate the vaccine effectiveness of BNT162b2 (Fosun-BioNTech) and Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Caige, Wei, Yue, Yan, Vincent K C, Ye, Xuxiao, Kang, Wei, Yiu, Hei Hang Edmund, Shami, Jessica J P, Cowling, Benjamin J, Tse, Man Li, Castle, David J, Chui, Celine S L, Lai, Francisco T T, Li, Xue, Wan, Eric Y F, Wong, Carlos K H, Hayes, Joseph F, Chang, Wing Chung, Chung, Albert K K, Lau, Chak Sing, Wong, Ian C K, Chan, Esther W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191606/
https://www.ncbi.nlm.nih.gov/pubmed/37141907
http://dx.doi.org/10.1016/S2215-0366(23)00111-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191606/
https://www.ncbi.nlm.nih.gov/pubmed/37141907
http://dx.doi.org/10.1016/S2215-0366(23)00111-6

Ejemplares similares